Experimental drug shows promise for tough anemia cases, but study halted early
NCT ID NCT04854889
First seen Feb 12, 2026 · Last updated May 04, 2026 · Updated 12 times
Summary
This study tested a low-dose chemotherapy drug called decitabine in people with a severe type of anemia (aplastic anemia) that did not get better with standard treatments. The goal was to see if the drug could improve blood cell counts. Only 3 people were enrolled before the study was stopped early, so the results are very limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY APLASTIC ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Regenerative Medicine Center
Tianjin, Tianjin Municipality, China
Conditions
Explore the condition pages connected to this study.